CYP4F44P

Across TCGA pan-cancer cohorts, CYP4F44P RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated CYP4F44P data layer.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher CYP4F44P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated CYP4F44P expression acts as an unfavorable survival marker, although some lineages such as HNSC show a favorable association.

COAD, SKCM, and BLCA are the cancer types where CYP4F44P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	OS	Tertile	All	0.452	0.872	<.001	162	view →
SKCM	DFS	Tertile	All	0.370	0.768	<.001	39	view →
BLCA	OS	Tertile	All	0.161	0.692	<.001	36	view →
STAD	DFS	Tertile	All	0.134	0.507	.012	27	view →
KIRC	DFS	Tertile	III,IV	0.070	0.745	<.001	18	view →
UCEC	OS	Tertile	IV	0.231	0.592	.036	18	view →
ACC	DFS	Tertile	II,III,IV	0.158	0.550	.011	12	view →
KICH	OS	Tertile	All	0.648	0.972	.012	9	view →
SARC	DFS	Tertile	All	0.405	0.620	.033	9	view →
LIHC	OS	Tertile	All	0.150	0.560	.048	9	view →
DLBC	OS	Tertile	All	0.219	0.900	.043	6	view →
HNSC	OS	Tertile	IV	0.901	0.351	.043	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

CYP4F44P–COAD (OS)

Open the COAD breakdown →